Phase II study of chemotherapy and stem cell transplantation for adult acute lymphoblastic leukemia or lymphoblastic lymphoma: Japan Clinical Oncology Group study 9004

Kensei Tobinai, Kunihiko Takeyama, Fumito Arima, Keiko Aikawa, Tohru Kobayashi, Shuichi Hanada, Masaharu Kasai, Michinori Ogura, Eisaburo Sueoka, Kiyoshi Mukai, Kinuko Tajima, Haruhiko Fukuda, Shigeru Shirakawa, Tomomitsu Hotta, Masanori Shimoyama, C. Mikuni, K. AIkawa, M. Kasai, Y. Kiyama, I. MiuraA. Miura, T. Sai, Y. Sasaki, K. Itoh, M. Shimoyama, K. Tobinai, K. Minato, T. Takenaka, K. Takeyama, A. Kohno, U. Sawada, I. Aoki, K. Kawano, T. Ibuka, T. Miwa, A. Togawa, H. Yamada, S. Iwase, K. Deura, S. Seki, M. Ogura, Y. Kagami, H. Suzuki, H. Nagai, T. Kinoshita, M. Hirano, M. Okamoto, S. Shirakawa, T. Kobayashi, M. Masuya, M. Yamaguchi, S. Konda, Y. Masaki, T. Susuki, S. Fukuhara, H. Ohno, T. Abe, M. Taniwaki, Y. Ohno, S. Irino, M. Nagai, N. Uike, S. Okamoto, K. Fujita, Y. Izumi, Y. Shimamoto, H. Fukushima, K. Yamaguchi, K. Takatsuki, M. Matsumoto, S. Hanada, K. Uozumi, A. Utsunomiya, K. Araki, I. Ohshiro

Research output: Contribution to journalArticlepeer-review

10 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Phase II study of chemotherapy and stem cell transplantation for adult acute lymphoblastic leukemia or lymphoblastic lymphoma: Japan Clinical Oncology Group study 9004'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science